Infertility Testing Market is expected to reach US$ 871.3 Million by 2031

Rising Global Incidence of Infertility Drives Infertility Testing Market Growth   

According to our latest study, “Infertility Testing Market Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis – by Technology, End Users, Application, and Geography," the market was valued at US$ 494.7 million in 2024 and is expected to reach US$ 871.3 million by 2031; it is estimated to record a CAGR of 8.6% during 2025–2031. The report includes prospects owing to the current infertility testing market trends and their foreseeable impact during the forecast period.    
 
The rising global incidence of infertility drives the infertility testing market growth, as more individuals and couples seek answers and solutions to reproductive challenges. According to recent estimates from the World Health Organization (WHO), approximately one in six people of reproductive age experience infertility at some point in their lives, underscoring the widespread nature of the condition across countries and economic levels. This prevalence highlights a substantial underlying demand for diagnostic services to identify causes and guide effective treatment plans. In April 2023, the WHO released a major report estimating that 1 in 6 people worldwide are affected by infertility at some point in their lives, stressing that this condition affects all regions and income groups and urgently requires expanded access to quality fertility care, including diagnosis and testing. The WHO emphasized the need for safe, effective, and affordable fertility services globally, signaling increased global health focus on infertility.

Infertility Testing Market Analysis — by Geography 

---

Infertility Testing Market Size, Trends & Forecast 2031

Download Free Sample

---

Infertility Testing Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Female Infertility Testing and Male Infertility Testing), Test Kits (Human Follicular Stimulating Hormone (FSH) Test Kits, Luteinizing Hormone (LH) Test Kits, Human Chorionic Gonadotropin (HCG) Hormone Test Kits, and Others), Sample (Blood, Urine, and Others), End Use (Homecare, Hospital and Clinics, and Fertility Centers), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)

Source: The Insight Partners Analysis

Quest Diagnostics Inc, Church & Dwight Co Inc, Swiss Precision Diagnostics GmbH, bioMérieux SA, QuidelOrtho Corp, Abbott Laboratories, Thermo Fisher Scientific Inc, Prestige Consumer Healthcare Inc., LetsGetChecked, and Mira are among the key players profiled in the infertility testing market report. Other players were also studied and analyzed during the market study to get a holistic view of the market and its ecosystem. 

The report includes the infertility testing market forecast by type, test kits, sample, and end use. Based on type, the global infertility testing market is bifurcated into female infertility testing and male infertility testing. The female infertility testing segment encompasses a variety of diagnostic procedures aimed at identifying underlying causes of infertility in women. Key tests include hormonal profiling, ovarian reserve assessment, hysterosalpingography (HSG), pelvic ultrasounds, and laparoscopy. Hormonal profiling evaluates levels of hormones such as FSH, LH, AMH, and prolactin, which play critical roles in ovulation and reproductive health. Ovarian reserve testing helps determine the quantity and quality of a woman’s eggs, aiding in predicting fertility potential. HSG and hysterosonography are employed to examine the uterine cavity and fallopian tube patency, detecting structural abnormalities or blockages. Advanced imaging and minimally invasive procedures, including laparoscopy, are used for diagnosing conditions such as endometriosis or pelvic adhesions, which may impair fertility. This segment held the largest infertility testing market share in 2024. 

The scope of the infertility testing market report focuses on North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). Asia Pacific dominated the market in 2024, followed by North America and Europe.

The infertility testing market in Asia Pacific is segmented into Australia, China, Japan, India, South Korea, and the Rest of Asia Pacific. In terms of revenue, China held the largest infertility testing market share in APAC. China represents a large infertility testing market within the Asia Pacific, shaped by demographic shifts and rising reproductive health awareness. Urban lifestyle pressures, delayed family formation, pollution, and rising infertility incidence have increased demand for comprehensive fertility screening — from hormone assays to advanced imaging and semen analysis. China’s large population and digital health ecosystem enable reproductive health platforms to integrate online ordering of test kits, teleconsultations, and AI-assisted cycle monitoring, making testing more convenient. Government concern over declining birth rates has encouraged public health messaging and expanded access to reproductive services. In August 2025, China’s National Health Commission responded to legislative suggestions by emphasizing expanded fertility screening, pre-conception counseling, and standardizing fertility assessment alongside broader reproductive health services.

Contact Us

Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com